Lund Melanoma Study Group
1 – 10 of 279
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Modeling anti-tumor immune responses using patient-derived melanoma organoids
- Contribution to journal › Article
-
Mark
Image enhancements by CLAHE and gamma correction do not improve diagnostic accuracy in teledermoscopy: a retrospective cohort study
- Contribution to journal › Article
-
Mark
Spatial and temporal dynamics of cancer-associated fibroblast niches in breast cancer
- Contribution to journal › Article
-
Mark
Interplay between AIB1 genotypes and radiotherapy in a Swedish population-based breast cancer cohort
- Contribution to journal › Article
-
Mark
Carcinoma of the parotid Gland : A Population-Based study of incidence and treatment outcomes in 1018 patients
- Contribution to journal › Article
-
Mark
Characteristics and overall survival in patients with T1 melanoma : A nationwide matched cohort study
- Contribution to journal › Article
-
Mark
Five-year survival after introduction of adjuvant treatment in stage III melanoma : A nationwide registry-based study
- Contribution to journal › Article
-
Mark
National Learning Objectives in Dermatology and Venereology for the New Swedish Medical Programme
- Contribution to journal › Article
-
Mark
Desmoplastic melanoma in Sweden in 2009–2022 : A population-based registry study demonstrating distinctive tumour characteristics, incidence and survival trends
- Contribution to journal › Article
-
Mark
Comment on ‘Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma : a nationwide population-based registry study from Sweden’: reply from the authors
- Contribution to journal › Letter
